Matches in Wikidata for { <http://www.wikidata.org/entity/Q88934162> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q88934162 description "article scientifique publié en 2018" @default.
- Q88934162 description "artículu científicu espublizáu en mayu de 2018" @default.
- Q88934162 description "scientific article published on 28 May 2018" @default.
- Q88934162 description "wetenschappelijk artikel" @default.
- Q88934162 description "наукова стаття, опублікована в травні 2018" @default.
- Q88934162 name "Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial" @default.
- Q88934162 name "Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial" @default.
- Q88934162 type Item @default.
- Q88934162 label "Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial" @default.
- Q88934162 label "Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial" @default.
- Q88934162 prefLabel "Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial" @default.
- Q88934162 prefLabel "Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial" @default.
- Q88934162 P1433 Q88934162-F0450321-26FF-4EFA-AF73-24D07867B5F7 @default.
- Q88934162 P1476 Q88934162-4C41924F-DDAE-48BC-817E-BDDD1043C4A6 @default.
- Q88934162 P2093 Q88934162-95DD9698-ED51-483C-981B-B281E77A6224 @default.
- Q88934162 P2093 Q88934162-99927CC0-A507-4344-BD2A-9F911CB858F5 @default.
- Q88934162 P2093 Q88934162-D8475F01-F37B-4F1E-865C-C1BE2C766F17 @default.
- Q88934162 P304 Q88934162-22517DD7-7BD5-45DD-B12C-9411423CCDAB @default.
- Q88934162 P31 Q88934162-60C6924E-2FB8-477F-A8F2-95B2A1476581 @default.
- Q88934162 P356 Q88934162-D309282E-D116-492F-B6D2-8B4C5A04F946 @default.
- Q88934162 P478 Q88934162-0F01FC0A-590F-4E8B-B93B-FFB3B85F9674 @default.
- Q88934162 P577 Q88934162-F40C6453-40F1-4CC8-AD8B-339EE662B1C1 @default.
- Q88934162 P698 Q88934162-148BDD4B-527C-41BB-AA95-64F20DF8E505 @default.
- Q88934162 P921 Q88934162-57F58298-6B6F-48A3-8807-B064186F829C @default.
- Q88934162 P921 Q88934162-711B5E87-CFF1-4FAD-A52E-3DD6D6790EAF @default.
- Q88934162 P921 Q88934162-BA631968-4FFA-4DEE-9CC1-F341B15FCC1A @default.
- Q88934162 P356 J.NEULET.2018.05.030 @default.
- Q88934162 P698 29852208 @default.
- Q88934162 P1433 Q7002625 @default.
- Q88934162 P1476 "Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial" @default.
- Q88934162 P2093 "Ning Ding" @default.
- Q88934162 P2093 "Zengxun Liu" @default.
- Q88934162 P2093 "Zhiqiang Li" @default.
- Q88934162 P304 "68-72" @default.
- Q88934162 P31 Q13442814 @default.
- Q88934162 P356 "10.1016/J.NEULET.2018.05.030" @default.
- Q88934162 P478 "681" @default.
- Q88934162 P577 "2018-05-28T00:00:00Z" @default.
- Q88934162 P698 "29852208" @default.
- Q88934162 P921 Q1436668 @default.
- Q88934162 P921 Q41112 @default.
- Q88934162 P921 Q423757 @default.